Methyltransferase G9a promotes cervical cancer angiogenesis and decreases patient survival

SUPPLEMENTARY MATERIALS
H3K9me2 immunohistochemical staining of human cervical cancer tissue
A cervical cancer tissue array section (CXC1021, US Biomax) containing both cervical cancer and normal tissue was deparaffinized in xylene and rehydrated using graded concentrations of alcohol to distilled water. After antigen retrieval by heat treatment in a 0.1 M citrate buffer at pH 6.0, endogenous peroxidase activity was blocked using a 3% H2O2 solution. Slides were then incubated for 30 minutes in 2.5% normal donkey serum or goat serum. Afterward, the slides were incubated overnight at 4°C with an antibody against H3K9me2 (D85B4), followed by incubation with secondary antibodies according to the manufacturer's instructions. Finally, antibody binding was detected using the avidin-biotin-peroxidase method. Reaction products were developed using 3', 5'-diaminobenzidine (Dako, Glostrup, Denmark) as a substrate for peroxidase. Sections were counterstained with Mayer's hematoxylin. All washes were performed using a phosphate-buffered saline solution (pH 7.4). Nuclear staining was considered as positive for H3K9me2 staining.
Evaluations of the efficiency of G9a siRNA
G9a siRNA efficiency was confirmed by detecting G9a mRNA expression via q-RTPCR (as described) using Real-time quantitative RT-PCR. G9a siRNA efficiency for G9a protein expression was confirmed using western blot as described above.
Human interleukin-8 (IL-8) promoter-reporter assay
To evaluate the effect G9a has on IL-8 promoter activity, cervical cancer cells were treated with G9a siRNA or control siRNA for 24 hrs. These cells were then transfected with human IL-8-1.4 Kb promoterdriven luciferase plasmids (BD Bioscience) using the Transfast transfection reagent (Promega). At 24 hrs after transfection, the luciferase activities were determined by Luminescence Reader (Beckman DTX880).
MVD assessment in cervical cancer tissue
Cervical cancer tissue sections from survival proportions and G9a expression pattern groups were further used for CD31 staining for microvessel density assessment. Slides were processed for immunohistochemical staining. The slides were incubated overnight at 4°C with antihuman CD31 (Santa Cruz Biotechnology); immunohistochemical reactions for CD31 were observed at LPF (40x) and positive stainings of CD31 were counted in 5 representative HPFs (400x; 0.152 mm 2 ; 0.44-mm diameter) for each tumor section. Single immunoreactive endothelial cells, or endothelial cell clusters separate from other microvessels, were counted as individual microvessels. Endothelial staining of large vessels with tunica media and nonspecific staining of nonendothelial structures were disregarded in microvessel counts. The mean visual CD31 staining for MVD was calculated. H3K9me2 expression for normal and cancer cells, a cervical cancer tissue array (CXC1021, US Biomax) containing both cervical cancer and normal tissue was stained using the H3K9me2 antibody. In contrast to normal cervical epithelium (NE) where H3K9me2 presented only a weak staining, a strong and condensed nuclear brown staining was found for adenocarcinoma (AdCA) and squamous cell carcinoma (SCC) cancer cells. 
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